Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinosarcoma × cediranib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Neoplasms 4 Sarcoma, Alveolar Soft Part 3 Sarcoma 3 Prostatic Neoplasms 3 Gliosarcoma 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Uveal Melanoma 2 Uterine Cervical Neoplasms 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoid Interstitial Pneumonia 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1

Interventions

Nivolumab 5 Paclitaxel 3 olaparib 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 rucaparib 1 pazopanib 1 pamiparib 1 durvalumab 1 ceralasertib 1 cediranib 1 cabozantinib 1 Ipilimumab 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡